These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 23475207)

  • 1. Testosterone and cardiovascular risk.
    Tirabassi G; Gioia A; Giovannini L; Boscaro M; Corona G; Carpi A; Maggi M; Balercia G
    Intern Emerg Med; 2013 Apr; 8 Suppl 1():S65-9. PubMed ID: 23475207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testosterone, cardiovascular disease and the metabolic syndrome.
    Corona G; Rastrelli G; Vignozzi L; Mannucci E; Maggi M
    Best Pract Res Clin Endocrinol Metab; 2011 Apr; 25(2):337-53. PubMed ID: 21397202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low testosterone syndrome protects subjects with high cardiovascular risk burden from major adverse cardiovascular events.
    Corona G; Rastrelli G; Maseroli E; Fralassi N; Sforza A; Forti G; Mannucci E; Maggi M
    Andrology; 2014 Sep; 2(5):741-7. PubMed ID: 25044637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular effect of testosterone replacement therapy in aging male.
    Francomano D; Bruzziches R; Natali M; Aversa A; Spera G
    Acta Biomed; 2010; 81 Suppl 1():101-6. PubMed ID: 20518199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Male hypogonadism and civilization diseases].
    Stárka L
    Cas Lek Cesk; 2012; 151(2):69-72. PubMed ID: 22515012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testosterone deficiency.
    Traish AM; Miner MM; Morgentaler A; Zitzmann M
    Am J Med; 2011 Jul; 124(7):578-87. PubMed ID: 21683825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testosterone therapy improves the clinical response to conventional treatment for male patients with metabolic syndrome associated to late onset hypogonadism.
    La Vignera S; Calogero AE; D'Agata R; Di Mauro M; Tumino S; Condorelli R; Lanzafame F; Finocchiaro C; Giammusso B; Vicari E
    Minerva Endocrinol; 2008 Sep; 33(3):159-67. PubMed ID: 18846023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relevant clinical and biological criteria for the diagnosis of androgen deficiency in the aging male (ADAM)].
    Seisen T; Rouprêt M; Gallais JL; Costa P
    Prog Urol; 2012 Jun; 22 Suppl 1():S21-6. PubMed ID: 22770497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen replacement therapy in late-onset hypogonadism: current concepts and controversies - a mini-review.
    Mäkinen JI; Huhtaniemi I
    Gerontology; 2011; 57(3):193-202. PubMed ID: 20689266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testosterone and Cardiovascular Risk: Meta-Analysis of Interventional Studies.
    Corona G; Rastrelli G; Di Pasquale G; Sforza A; Mannucci E; Maggi M
    J Sex Med; 2018 Jun; 15(6):820-838. PubMed ID: 29803351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Testosterone in old age: an up-date].
    Hilbert-Walter A; Büttner R; Sieber C; Bollheimer C
    Dtsch Med Wochenschr; 2012 Oct; 137(41):2117-22. PubMed ID: 23033170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dark side of testosterone deficiency: III. Cardiovascular disease.
    Traish AM; Saad F; Feeley RJ; Guay A
    J Androl; 2009; 30(5):477-94. PubMed ID: 19342698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late-life onset hypogonadism: a review.
    Bassil N; Morley JE
    Clin Geriatr Med; 2010 May; 26(2):197-222. PubMed ID: 20497841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen therapy in men with testosterone deficiency: can testosterone reduce the risk of cardiovascular disease?
    Saad F
    Diabetes Metab Res Rev; 2012 Dec; 28 Suppl 2():52-9. PubMed ID: 23280867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome and hypogonadism--two peas in a pod.
    Ebrahimi F; Christ-Crain M
    Swiss Med Wkly; 2016; 146():w14283. PubMed ID: 26999489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testosterone and the Heart.
    Goodale T; Sadhu A; Petak S; Robbins R
    Methodist Debakey Cardiovasc J; 2017; 13(2):68-72. PubMed ID: 28740585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testosterone and ageing: what have we learned since the Institute of Medicine report and what lies ahead?
    Miner MM; Seftel AD
    Int J Clin Pract; 2007 Apr; 61(4):622-32. PubMed ID: 17343664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testosterone and cardiovascular disease--the controversy and the facts.
    Morgentaler A; Feibus A; Baum N
    Postgrad Med; 2015 Mar; 127(2):159-65. PubMed ID: 25708023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgens and cardiovascular disease.
    Yeap BB
    Curr Opin Endocrinol Diabetes Obes; 2010 Jun; 17(3):269-76. PubMed ID: 20186051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of androgens on the cardiovascular system.
    Rosano GM; Cornoldi A; Fini M
    J Endocrinol Invest; 2005; 28(3 Suppl):32-8. PubMed ID: 16042358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.